Assessing Tomotherapy Performance Post-Linac Replacement: A Dosimetric Comparison with Manufacturer's Gold Data
Abstract
Keywords
References
- [1]. Balog J, Olivera G, Kapatoes J. 2003. Clinical helical tomotherapy commissioning dosimetry. Med Phys;30(12):3097–106.
- [2]. Jeraj R, Mackie TR, Balog J, John Balog, 2004. Gustavo Olivera, Dave Pearson, Jeff Kapatoes, Ken Ruchala, Paul Reckwerdt. Radiation characteristics of helical tomotherapy. Med Phys; 31(2):396–404.
- [3]. Langen KM, Papanikolaou N, Balog J, Crilly R, Followill D, Goddu SM, Grant W, Olivera G, Ramsey CR, Shi C. 2010. QA for helical tomotherapy: report of the AAPM Task Group 148. Med Phys. Sep;37(9):4817-53.
- [4]. Zhao YL, Mackenzie M, Kirkby C, Fallone BG. 2008. Monte Carlo calculation of helical tomotherapy dose delivery. Med Phys; 35(8):3491–500.
- [5]. Jean L. Peng,a Michael S. Ashenafi, Daniel G. McDonald, Kenneth N. Vanek. 2015. Assessment of a three-dimensional (3D) water scanning system for beam commissioning and measurements on a helical tomotherapy unit. Journal Of Applıed Clınıcal Medıcal Physıcs, Volume 16, Number 1.
- [6]. Göksel E, Barlaz Us S, Akdeniz Y, Bozca R, Elçim Y, Gani Z, Güray G, Dede Karakoç N, Nalbant N, Toksoy T, Yeşil A. 2024. Guide For Quality Control and Quality Assurance Tests in Tomotherapy/Radixact Systems. Turk J Oncol 2024;39(Supp 1):31–5.
- [7]. Günhan B. 2010. Helikal Tomoterapi’de Hasta Kalite Kontrolünde Dozimetrik Yöntemlerin Karşılaştırılması. İstanbul Ünversitesi Sağlık Bilimleri Enstitüsü Doktora Tezi İstanbul.
- [8]. Sharma SD. 2011. Unflattened photon beams from the standard flattening filter free accelerators for radiotherapy: Advantages, limitations and challenges Med Phys. 2011 Jul-Sep;36(3):123–125.
Details
Primary Language
English
Subjects
Biomedical Instrumentation
Journal Section
Research Article
Authors
Eda Kaya Pepele
*
0000-0002-9193-0961
Türkiye
Publication Date
December 29, 2025
Submission Date
February 4, 2025
Acceptance Date
May 29, 2025
Published in Issue
Year 2025 Volume: 21 Number: 4